JUDITH KORNFELD

+1-971-***-**** ● add2le@r.postjobfree.com

Versatile, performance focused leader with vast experience and solid scientific background driving global business and collaboration initiatives for medical device and biotech organizations, Expertise in creating and leading strategic alliances, developing long-term vision, and promoting innovative solutions that position organizations at the forefront of the biotech industry. Effective leader distinguished for exceptional communication skills, ability to manage and nurture talent and form collaborative internal and external partnerships. Areas of expertise include:

Strategy & Vision Development ● Licensing ● Negotiations ● Collaborations ● Innovation ● IP

Start-Ups ● Business Development ● Alliance Management ● Digital Biomarkers ●

Deal Structures ● Academia-Industry Collaborations ● Relationship Builder ● Tech Transfer

Digital In-Home Technologies ● Research Commercialization ● Exceptional Presentation Skills

PROFESSIONAL EXPERIENCE

ORCATECH, Oregon Health and Science University, Portland, OR May 2013 – Present

Chief Business and Operations Officer

Technology development center for digital and wearable sensor-based platform technologies (www.orcatech.org) revolutionizing clinical trials and product development. Successfully led a multidisciplinary team of engineers, technicians, clinicians and scientists developing technology and big data assets that are now widely used in both industry and academia/

·Allied with lead pharmaceutical companies on adoption of ORCATECH’s technologies for use in clinical trials

·Led the CART (www.carthome.org) NIH Initiative partnering and collaborations operations

·Promoted the use of ORCATECH technology with key industry leaders and the FDA

·Managed R&D group, P&L and on-going operations of center

·Initiated and completed funding and licensing transaction with a Canadian VC: Nexvue Capital

·Created collaborations to expedite development of technologies

·Developed and executed business, marketing and commercialization strategy, capitalizing on the potential of sensor-based technologies and data analysis through utilization in innovative clinical trials

·Built robust patent strategy, leveraging value of innovative assets of proprietary technologies

TransPharma Medical, Tel Aviv, Israel/Portland, OR October 2002 – February 2012

Vice President, Business Development

Specialty pharmaceutical company focused on the development and commercialization of drug products for treatment of diseases in various domains using proprietary active transdermal drug delivery technologies. Recruited by President/CEO during start-up phase to establish commercial strategy and lead business and corporate development efforts

·Initiated, crafted and negotiated licensing, development and marketing agreement with Eli Lilly for ViaDerm-hPTH (1-34) osteoporosis treatment product, a major agreement in the transdermal industry, generating $35M of immediate revenue and potential additional significant revenue through milestones and royalties

·Scouted broadly for technology utilizations in various clinical areas to build a robust product pipeline

·Brought together three major pharmaceutical companies to jointly bid and conduct due diligence

·Lead the alliance management team for the development of the TransPharma-Lilly product and negotiated agreements on behalf of the alliance

·Initiated, negotiated and led to execution numerous feasibility, co-development agreements and term sheets with major companies such as Novartis, Pfizer, P&G, TEVA, UCB, Serono, Schering, Ferring and more

·Presented company’s innovations in major industry conferences and oversaw all marketing activities

·Crafted deals that specifically pertain to platform technologies including the unique IP positioning

·Established a U.S. subsidiary for business development and alliance management activities

·Evaluated M&A, in-licensing, and exit opportunities on behalf of the board of directors

·Collaborated with CEO to raise capital in three funding rounds

Notal Vision, LTD., Tel Aviv, Israel August 2001 – September 2002

Vice President, Business Development

Ophthalmology-focused company developing diagnosis devices for diabetes related AMD. Recruited by founding ophthalmologists to initiate and direct business development and intellectual property activities for start-up.

·Instrumental in finalizing major licensing agreement with Zeiss Company, a major ophthalmic global company

·Recognized for securing major monetary grant from Bird Foundation, leading to the award of promising projects based on U.S.-Israeli collaborations

·Developed business and IP strategies, directed marketing activities and recruited team members while participating in regulatory and clinical affairs

Impulse Dynamics, LTD., Tirat Hakarmel, Israel December 1997 – August 2001

Vice President, Business Development & IP

Bio-Medical Device Company specializing in cardiology, diabetes and gastroenterology. One of three key executives leading growth of a medical device company with 50 employees, directing recruitment of engineers and scientists, structuring budget and managing financial functions.

·Secured $400M in revenue by initiating and leading business strategy while serving as negotiating team member of agreement with Guidant

·Developed a portfolio of 80 patents in collaboration with engineers, scientists and physicians

Previous experience includes:

·Carmel Medical Center/World Health Organization, Project Director

·Duke University, Research Technician

·Israeli Navy/Headquarters, Lieutenant

EDUCATION & TRAINING

Rollins College, Crummer Graduate School of Business, MBA (Honors)

Israel Institute of Technology, Bachelor’s in Life Sciences (Cum Laude)

Israel Institute of Technology, Undergraduate Coursework: Electrical Engineering Department

Training: Financial Negotiation Skills (PharmaVentures), Finance Management (MILA), Winning Presentation (Tack International), Tools for Managing R&D and Intellectual Property Assets, European Patent Office Practice (EPO), Basic Patent Cooperation Treaty Practice (WIPO)

PRESENTATIONS/PUBLICATIONS/PATENTS

MEDinISRAEL, Speaker, 2019

Partnerships in Clinical Trials (PCT), Speaker, 2015 and 2018

Big Data in Pharma Conference, Speaker, 2014

Annual Drug Delivery Partnerships Conference, Speaker, 2004 – 2011

Bio Europe, Speaker, 2006 – 2009

Publications: 1. Levin G. & Kornfeld J. (2008). RF-Microchannel-Based Transdermal Delivery.

Innovations in Pharmaceutical Technology.

2. Dodge HH, Zhu J, Mattek NC, Austin D, Kornfeld J, Kaye JA (2015) Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials. PLoS ONE. 10(9)

Patents: US20020055764 (Multi-Electrode Lead); US7460907 (Pacing with Hemodynamic Enhancement)

PROFESSIONAL AFFILIATIONS

Oregon Biosciences Association

Beta Gamma Sigma Association

GLG Council Member

Contact this candidate